Connect with us

Cannabis News

4 In 5 Marijuana Consumers Oppose Hemp THC Ban Trump Signed Ahead Of Rescheduling And CBD Access Order, Poll Shows

Published

on

Four out of five marijuana users say they oppose the recriminalization of hemp THC products a spending bill President Donald Trump signed into law in November, just weeks before he ordered the rescheduling of cannabis and took steps to protect access to full-spectrum CBD.

However, the current law would redefine hemp in a way that industry players believe, after Trump legitimized the sector during his first term when it was federally legalized under the 2018 Farm Bill.

While there has been some division between marijuana and hemp interests over the THC ban that goes into effect next November, an overwhelming majority of cannabis users (82 percent) said they are waiting to oppose the policy change.

That’s according to a new survey conducted by cannabis telehealth platform NuggMD, which asked marijuana users to weigh in on the law’s provisions to recriminalize hemp THC.

Only 4% of respondents said they support the ban, while 15% have no opinion on the policy.

Q: “The president recently signed legislation recriminalizing hemp-derived THC, which became legal in 2018. Do you support or oppose this policy?”
n: %
I am against politics. Hemp THC must be legal. 365 81.5%
I have no opinion on politics. 67 15.0%
I support the policy. Hemp THC should be banned. 16 3.6%

The survey interviewed 448 cannabis users living in the state’s legal markets between December 4th and 14th, with a margin of error of +/-4.63 points.

The survey came just weeks before Trump signed an executive order directing the attorney general to complete the process of moving marijuana from Schedule I to Schedule III of the Controlled Substances Act (CSA).

Part of that announcement also has implications for the upcoming hemp law. The president’s executive order also asked Congress consider updating the definition of hemp to ensure that full-spectrum CBD is available to patients.

Another redefinition of hemp would be part of a novel proposal allow Medicare recipients to access non-toxic CBD that would be covered under the federal health care plan.

To make this happen, the Centers for Medicare and Medicaid Services (CMS) will “enable a model that will allow certain CMS beneficiaries to benefit from receiving CBD at no cost on the basis of a physician’s recommendation,” a White House official announced in a briefing. Marihuana Moment first reported the leaked details ahead of the signing event.

“The December 18 Executive Order on Cannabis makes it clear that the White House has a real CBD agenda,” Andrew Graham, director of communications at NuggMD, told Marijuana Moment. “We looked at the popularity of recent congressional efforts to regulate hemp, because right now that policy is a big obstacle to that agenda.”

“Cannabis users are key players in this policy debate because they are directly affected by another ban on THC hemp, so their voice belongs in the conversation,” he said. “Also, there’s a practical question about the ban, because I don’t know how you would do a federal policy that bans THC but doesn’t ban CBD. Given the popularity of hemp THC products, I see this as a choice situation and I’m not going to pretend to know which side will prevail.”

Trump appeared to support a more flexible CBD policy over the summer shared a video calling for that exact reform while promoting the health benefits of cannabidiolespecially for the elderly.

Meanwhile, it would make way for the recently introduced bill in the Republican-led Congress stop implementing the hemp ban under established credit legislation.

Hemp companies and industry groups have warned about the potential ramifications of the ban, but despite states in support of cannabis rights and a recent social media post extolling the benefits of CBD, Trump signed the underlying spending measure into law without endorsing the hemp provisions.

GOP political operative Roger Stone recently said it was Trump effectively “forced” Republican lawmakers to sign the spending bill with language to ban hemp THC.

However, a White House spokesman said before signing the bill Trump was particularly supportive of the ban’s language.

The Democratic governor of Kentucky said that the hemp industry is an “important” part of the economy that deserves to be regulated at the state level—instead of being banned federally, as Congress has done—.

Additionally, a leading veterans organization is alerting Congressional leaders to the recently passed blanket ban on consumable hemp products. could inadvertently “close the door” on critical inquiry.


It’s Marijuana Moment tracking hundreds of cannabis, psychedelic and drug policy bills in state legislatures and Congress this year. Patreon supporters by pledging at least $25/month, you’ll get access to our interactive maps, charts, and audio calendars so you never miss a development.


Learn more about our marijuana bill tracking and become a Patreon supporter to gain access

Since 2018, cannabis products have been considered legal hemp if they contain less than 0.3 percent delta-9 THC by dry weight.

The new legislation specifies that, within a year of taking effect, the weight will be applied to total THC—including delta-8 and other isomers. Also, “as tetrahydrocannabinol (or any other marketed cannabinoid) with similar effects in humans or animals (as determined by the Secretary of Health and Human Services).”

The new definition of legal hemp will also prohibit “any hemp-derived cannabinoid intermediate product marketed or sold as an end product or directly to an end consumer for personal or home use” as well as products containing cannabinoids that are synthesized or manufactured outside of the cannabis plant or are unable to produce it naturally.

Legal hemp products will be limited to a total of 0.4 milligrams of total THC or any other cannabinoid with similar effects per container.

Within 90 days of the bill’s passage, the Food and Drug Administration (FDA) and other agencies must “publish a list of all cannabinoids known to the FDA to be naturally produced by a Cannabis sativa L. plant, as reflected in the peer-reviewed literature,” which include “all tetrahydrocannabinol classes known” in natural plants and “known cannabinoids.” cannabinoids that have or are marketed as having effects similar to cannabinoids of the tetrahydrocannabinol class.

The language differs slightly from provisions in legislation advanced out of the House and Senate Appropriations panels, which would have banned products with “quantifiable” amounts of THC, to be determined by the HHS secretary and the agriculture secretary.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Become a patron on Patreon!

Cannabis News

Bountiful Farms goes best in New England at NECANN Cup

Published

on

By

Bountiful Farms placed first and second in the licensed solvent-free concentrate division at this year’s NECANN Cup, then also won the mixed licensed and unlicensed division to win best overall, putting the Massachusetts operator in the running for best in show with the highest-scoring product in New England.

© Bountiful Farms

NECANN is the largest B2B cannabis event in New England and the second largest in the country, attracting over 9,000 attendees. Everything is unbranded. Licensed and unlicensed operators in the six New England states compete only in product. Zachary Taylor, Director of Agriculture at Bountiful Farms, says the win for Maine’s craft growers means a lot to him and his team. “Whenever you compete against Maine, with its regulations and the craft culture of the caretakers, to be considered a craft on our scale is the greatest honor. When you look at cups across the nation, you see cups of culture, and Maine is always well represented. To be recognized on the same playing field and to excel at this scale is very difficult, and I don’t think that’s what people mean.”

Of course, rosin isn’t given more forcefully to Bountiful Farms. But Zach in a clean way© Bountiful Farms he says, “A good raisin doesn’t appear out of nowhere. It comes from the flower.” The award-winning genetics were bred by Crystal Rose, and built around a high-resin, terpene-rich expression.

“The buds come in within 15 minutes of harvest, it’s like a timer,” Zach says. “Then we move them to a chest freezer, before moving them to an aisle freezer, where they’ll sit until they’re cleaned. All the rosin is pressed by hand in a hydraulic press.” At its scale, Bountiful Farms must use automation to achieve consistently high quality. “But we have very practical components,” he said. “The backlash of the press tells you how hard it is to go. Same approach with agitation, for example. The flower heads themselves, how we maintain the integrity of the trichome, the rise time of the wash, the temperatures: everything is handled like a small-scale race.”

That level of attention comes from the team. Matt Bearup, now a solventless QC manager, started growing and built the hash lab from the ground up all by himself. There are currently eight hash makers, all passionate about complex genetics and terpenes. Strains include not only the main terpenes, but also tasting notes and effects. Using the SC Lab framework, limonene as the current focus. “There’s not a lot of that in the hashish sector in particular. Several growers are moving in that direction.”

© Bountiful Farms

“There’s not a lot like it. Several breeders are moving in that direction.”

Bountiful Farms has been producing rosin since 2021, when the category had little traction© Bountiful Farms in Massachusetts. Since then, the company has expanded into a high-end cultivation center to produce even more rosin. They operate two production rooms and processes not only for themselves, but also for other clients including Native Sun, Breathe Free and u4ea. They have recently opened two new dispensaries, allowing them to expand into recreational retail from 2021. Another limited release of the full melt is planned, along with a dual-cartridge solvent-free pen developed with O2 Vapes, two flavors in one device.

“When you bring award-winning companies together, you get products that represent the industry at its best. Massachusetts deserves its place among the leaders in this industry. When we win, the industry wins.”

For more information:
Prosperous Farms
prosperous farm. take care of

Continue Reading

Cannabis News

Federal Drug Testing Rule Will Require ‘Directly Observed’ Urine Collection From Truck Drivers

Published

on

By

“A month that goes by without an oral fluid test is another month when federal employees with paruresis face anxiety, discrimination, and barriers.”

By Kastalia Medrano, Filter

The Department of Transportation will require “directly observed” urine drug testing in federal employment situations where saliva testing is required but not possible. The clarification of DOT drug and alcohol testing procedures is the latest development in a years-long push by the trucking industry. oral fluid testing as an alternative to urine testing.

The new rule was published in the Federal Register on May 11, and will go into effect on June 10.

Truck drivers, who are subject to a large number of federal regulations, do not choose the method of drug testing, while DOT-regulated employers do. The campaign to implement oral fluid testing has been led by the American Trucking Association (ATA), which believes it is necessary to “keep drivers with disabilities off the road and maintain the trucking industry’s commitment to safety.”

The Substance Abuse and Mental Health Services Administration (SAMHSA) approved lab-based oral fluid testing in 2019, and the DOT finalized its regulations in 2023 allowing employers to choose this as an alternative to urine testing. But the actual implementation requires at least. Two laboratories approved by the Food and Drug Administration to process tests—one for the initial analysis and another to confirm the results. There are currently zero.

Oral fluid testing is attractive to many employers for a number of reasons, one of which is its effectiveness in detecting drug use within hours compared to urine drug testing. While the trucking industry has become the public face of the campaign, the regulations also affect federal workers in the commercial aviation, railroad, public transportation and pipeline sectors.

One of the main concerns expressed by the trucking industry has been that urine drug screens are not visible, making it easier to avoid oral fluid testing. Another concern is paruresis, commonly referred to as “shy bladder” syndrome: if a driver can’t urinate when they need to, they’re stuck for a three-hour wait, which obviously affects their arrival time. And if they still cannot produce urine during this period, they are considered to have refused to take the test and are removed from their duties. To return, they must “pass” a urine test watched by a same-sex observer.

New DOT the rule also updates existing terminology by replacing the word “gender” with the word “sex” in accordance with President Donald Trump’s January 2025 executive order “Defending Women from Gender Ideological Extremism and Restoring Biological Truth to the Federal Government.”

“A month that goes without an oral fluid test is another month when federal employees with paruresis face anxiety, discrimination and professional barriers,” Dr. Steven Soifer, co-founder of the International Paruresis Society, said in March. “We have been working on this issue since our inception (30 years ago). Our members ask the same question every day: When will the federal government finish the work it has already approved?”

In April, at the request of ATA, six members of Congress he wrote Robert F. Kennedy Jr. to the Secretary of the Department of Health and Human Services citing FDA regulatory hurdles as the reason why laboratories in the United States are not certified to process oral fluid tests.

They cited an analysis by Quest Diagnostics that showed a 370 percent increase in “replaced” urine specimens from 2022 to 2023. Quest has its own laboratory-based oral fluid collection method, Quantisal™, and has therefore been an ardent supporter of the campaign.

On May 1, the FDA a notice with the intention of considering revising the requirements for toxicology studies. That same day SAMHSA a the list It confirms that currently certified laboratories, which will probably be updated in the future, but are not available at the moment.

However, at the end of the day, HHS handles oral fluid testing in a similar scenario to hair follicle testing. The department promised to create guidelines for hair testing in 2015, but has yet to do so.

This the article originally posted by The filteran online magazine that deals with drug use, drug policy and human rights from a harm reduction perspective. Follow Filter on Bluesky, X or Facebookand sign up for their newsletter.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Continue Reading

Cannabis News

TSA clarifies that cannabis policy has not changed

Published

on

By











Over the past week, many news organizations have been running exaggerated headlines about a supposed change by the federal government to allow marijuana to be brought into airports and airplanes. But it’s not true, the Transportation Security Administration (TSA) tells Marijuana Moment.

“TSA’s policy on medical marijuana has not changed,” a TSA spokeswoman said in an email Wednesday.

“According to the TSA website: If any illegal substance or evidence of criminal activity is found during the security screening, TSA will refer the matter to law enforcement,” they said. While it’s true that the agency’s list of medical marijuana “What can I bring?” section of its website was updated on April 27, there were no major changes in policy.

Currently, the website says “Yes,” passengers can carry medical marijuana in carry-on and checked bags with special instructions. But the TSA cannabis policy has said “Yes” to medical marijuana, with the same caveats, since 2019.

Read more at Marijuana Moment










Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media